Physician profile
Michelle Clark
NPI 1295080141
$1,054.95
in general payments reported to CMS, 2019-2025
13 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.00 · 2022: $144 · 2023: $425 · 2024: $305 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $389.59 | 2022-2024 | Watchman Flx |
| Edwards Lifesciences Corporation | $136.88 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cvrx, INC. | $128.05 | 2024-2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $110.73 | 2024 | Amvuttra |
| Stryker Corporation | $68.42 | 2023 | Stryker |
| Takeda Pharmaceuticals U.S.A., INC. | $52.44 | 2024 | Entyvio |
| Masimo Corporation | $46.69 | 2021-2022 | |
| Medtronic, INC. | $33.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.63 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $19.87 | 2022 | |
| Axonics, INC. | $18.09 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.63 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.37 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.